Распространение и антибактериальная резистентность грамотрицательных бактерий, продуцентов карбапенемаз, в Санкт-Петербурге и некоторых других регионах Российской Федерации
Аннотация
Об авторах
И. В. ЛазареваРоссия
В. А. Агеевец
Россия
Т. А. Ершова
Россия
Л. П. Зуева
Россия
А. Е. Гончаров
Россия
М. Г. Дарьина
Россия
Ю. С. Светличная
Россия
А. Н. Усков
Россия
С. В. Сидоренко
Россия
Список литературы
1. Glasner C., Albiger B, Buist G., Tambic Andrasevic A., Canton R., Carmeli Y., Friedrich A. W., Giske C.G., Glupczynski Y., Gniadkowski M., et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill 2013; 2013, 18 (28): pii=20525. Available online: http: //www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=20525.
2. Albiger B, Glasner C., Struelens M., Grundmann H., Monnet D., group. tESoC-PEEw: May 2015. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries,. Euro Surveill 2015; 20(45): pii=30062 DOI: http: //dxdoiorg/102807/1560-7917ES2015204530062 2015.
3. Агеевец B.A., Партина И.В., Лисицына Е.С., Батыршин И.М., Попенко Л.Н., Шляпников С.А., Ильина Е.Н., Сидоренко С.В. Первое обнаружние металло-бета-лактамазы NDM-типа в многопрофильном стационаре в России. Медицинский академический журнал 2012, 12: 43-45. / Ageevec V.A., Partina I.V., Lisicyna E.S., Batyrshin I.M., Popenko L.N., Shljapnikov S.A., Il'ina E.N., Sidorenko S.V. Pervoe obnaruzhnie metallo-beta-laktamazy NDM-tipa v mnogoprofil'nom stacionare v Rossii. Medicinskij akademicheskij zhurnal 2012, 12: 43-45. [in Russian]
4. Barantsevich E.P., Churkina I.V., Barantsevich N.E., Pelkonen J., Schlyakhto E.V., Woodford N. Emergence of Klebsiella pneumoniae producing NDM-1 carbapenemase in Saint Petersburg, Russia. Journal of Antimicrobial Chemotherapy 2013, 68: 1204-1206.
5. Ageevets V.A., Partina I.V., Lisitsyna E.S., Ilina E.N., Lobzin Y.V., Shlyapnikov S.A., Sidorenko S.V. Emergence of carbapenemase-producing Gram-negative bacteria in Saint Petersburg, Russia. Int J Antimicrob Agents 2014, 44: 152-155.
6. Сухорукова M.B., Эйдельштейн M.B., Скслеенова Е.Ю., Иватик Н.В., Тимохова A.B., Дехнич A.B., Козлов Р.С. Антибиотикорезистентность нозокомиальных штаммов Enteroacteriaceae в стационарах России: результаты многоцентрового эпидемиологического исследования Марафон в 2011-2012 гг. Клиническая микробиология и антимикробная химиотерапия 2014, 16: 254-265 / Suhorukova M.V., Jejdel'shtejn M.V., Sksleenova E.Ju, Ivanchik N.V., Timohova AV, Dehnich A.V., Kozlov R.S. Antibiotikorezistentnost' nozokomial'nyh shtammov Enteroacteriaceae v stacionarah Rossii: rezul'taty mnogocentrovogo jepidemiologicheskogo issledovanija Marafon v 2011-2012 gg. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija 2014, 16: 254-265. [in Russian]
7. Fursova N, Astashkin E, Knyazeva A., Kartsev N., Leonova E., Ershova O., Alexandrova I., Kurdyumova N., Sazikina S., Volozhantsev N. et al. The spread of blaOXA-48 and blaOXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia. Annals ofClinical Microbiology and Antimicrobials 2015, 14: 46.
8. Сидоренко С.В., Резван С.П., Еремина Л.В., Поликарпова С.В., Карабак В.И., Меньшикова Е.Д., Тишков В.И., Черкашин Е.А., Белобородов В.Б. Этиология тяжёлых госпитальных инфекций в отделениях реанимации и интенсивной терапии и антибиотикорезистентность возбудителей. Антибиотики и химиотерапия 2005, 50: 33-41./ Sidorenko S.V., Rezvan S.P., Eremina L.V., Polikarpova S.V., Karabak V.I., Men'shikova E.D., Tishkov V.I., Cherkashin E.A., Beloborodov V.B. Jetiologija tjazhelyh gospital'nyh infekcij v otdelenijah reanimacii i intensivnoj terapii i antibiotikorezistentnost' vozbuditelej. Antibiotiki i khimioterapija 2005, 50: 33-41. [in Russian]
9. Сухорукова М.В, Эйдельштейн М.В., Склеенова Е.Ю., Иватик Н.В., Тимохова А.В., Шек Е.А., Дехнич А.В., Козлов Р.С. «МАРАФОН» иг: Антибиотикорезистентность нозокомиальных штаммов Acinetobacter spp. в стационарах России: результаты многоцентрового эпидемиологического исследования МАРАФОН в 2011-2012 гг. Клин Микробиол Антимикроб Химиотер 2014; 2014, 16: 266-271. / Suhorukova M.V., Jejdel'shtejn M.V., Skleenova E.Ju., Ivanchik N.V., Timohova A.V., Shek E.A., Dehnich A.V., Kozlov R.S., «MARAFON» ig: Antibiotikorezistentnost' nozokomial'nyh shtammov Acinetobacter spp. v stacionarah Rossii: rezul'taty mnogocentrovogo jepidemiologicheskogo issledovanija MARAFON v 2011-2012 gg. Klin Mikrobiol Antimikrob Himioter 2014; 2014, 16: 266-271. [in Russian]
10. INTERNATIONAL STANDARD ISO 20776-1. Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases.
11. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 6.0. January 2016. http://www.eucast.org/clinical_ breakpoints/.
12. Pitout J.D., Nordmann P., Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother2015, 59: 5873-5884.
13. Chen L., Mathema B., Pitout J.D., DeLeo F.R., Kreiswirth B.N. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. MBio2014, 5: e01355-01314.
14. Borer A., Saidel-Odes L., Eskira S., Nativ R., Riesenberg K., Livshiz-Riven I., Schlaeffer F., Sherf M., Peled N. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K.pneumoniae. Am J Infect Control 2012, 40: 421-425.
15. Tzouvelekis L.S., Miriagou V., Kotsakis S.D., Spyridopoulou K., Athanasiou E., Karagouni E., Tzelepi E., Daikos G.L. KPC-producing, multidrug-resistant Klebsiella pneumoniae sequence type 258 as a typical opportunistic pathogen. Antimicrobial Agents and Chemotherapy 2013, 57: 5144-5146.
16. Tzouvelekis L.S., Markogiannakis A., Psichogiou M., Tassios P.T., Daikos G.L. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clinical Microbiology Reviews 2012, 25: 682-707.
17. Ageevets V., Sopova J., Lazareva I., Malakhova M., Ilina E., Kostryukova E., Babenko V., Carattoli A., Lobzin Y., Uskov A., Sidorenko S. Genetic environment of the blaKPC-2 gene in Klebsiella pneumoniae isolate which may have been imported to Russia from Southeast Asia. Antimicrobial Agents and Chemotherapy2016.
18. Falagas M.E., Lourida P., Poulikakos P., Rafailidis P.I., Tansarli G.S. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrobial Agents and Chemotherapy 2014, 58: 654-663.
19. Falagas M.E., Karageorgopoulos D.E., Nordmann P. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol 2011, 6: 653-666.
20. Lee G.C., Burgess D.S. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob 2012, 11: 32.
21. Morrill H.J., Pogue J.M., Kaye K.S., LaPlante K.L. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infectious Diseases 2015, 2.
22. Qureshi Z.A., Paterson D.L., Potoski B.A., Kilayko M.C., Sandovsky G., Sordillo E., Polsky B., Adams-Haduch J.M., Doi Y. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012, 56: 2108-2113.
23. Vourli S., Tsala M., Kotsakis S., Daikos G.L., Tzouvelekis L., Miriagou V., Zerva L., Meletiadis J. Comparison of short versus prolonged infusion of standard dose of meropenem against carbapenemase-producing Klebsiella pneumoniae isolates in different patient groups: a pharmacokinetic-pharmacodynamic approach. J Pharm Sci2016, 105: 1513-1518.
24. Daikos G.L., Tsaousi S., Tzouvelekis L.S., Anyfantis I., Psichogiou M., Argyropoulou A., Stefanou I., Sypsa V., Miriagou V., Nepka M. et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014, 58: 2322-2328.
25. Bassetti M., Peghin M., Pecori D. The management of multidrug-resistant Enterobacteriaceae. Curr Opin Infect Dis 2016, 29: 583-594.
26. Lenhard J.R., Bulitta J.B., Connell T.D., King-Lyons N., Landersdorfer C.B., Cheah S.-E., Thamlikitkul V., Shin B.S., Rao G., Holden P.N. et al. High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 2017, 72: 153-165.
27. Oliva A., D'Abramo A., D'Agostino C., Iannetta M., Mascellino M.T., Gallinelli C., Mastroianni C.M., Vullo V. Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections. J Antimicrob Chemother 2014, 69: 1718-1720.
28. Tasina E., Haidich A.B., Kokkali S., Arvanitidou M. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. The Lancet infectious diseases 2011, 11: 834-844.
29. Shen F., Han Q., Xie D., Fang M., Zeng H., Deng Y. Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs. Int J Infect Dis 2015, 39: 25-33.
30. Ni W., Han Y., Liu J., Wei C., Zhao J., Cui J., Wang R., Liu Y. Tigecycline treatment for carbapenem-resistant enterobacteriaceae infections: a systematic review and meta-analysis. Medicine (Baltimore) 2016, 95: e3126.
31. Ni W., Han Y., Zhao J., Wei C., Cui J., Wang R., Liu Y. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. Int J Antimicrob Agents 2016, 47: 107-116.
32. Sader H.S., Castanheira M., Flamm R.K., Mendes R.E., Farrell D.J., Jones R.N. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013). Diagn Microbiol Infect Dis 2015.
33. Kehl S.C., Dowzicky M.J. Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the tigecycline evaluation and surveillance trial. J Clin Microbiol 2015, 53: 1286-1293.
34. Yahav D., Farbman L., Leibovici L., Paul M. Colistin: new lessons on an old antibiotic. Clin Microbiol Infect 2012, 18: 18-29.
35. Liu Y.-Y., Wang Y., Walsh T.R., Yi L.-X., Zhang R., Spencer J., Doi Y., Tian G., Dong B., Huang X. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases 2016, 16: 161-168.
Рецензия
Для цитирования:
Лазарева И.В., Агеевец В.А., Ершова Т.А., Зуева Л.П., Гончаров А.Е., Дарьина М.Г., Светличная Ю.С., Усков А.Н., Сидоренко С.В. Распространение и антибактериальная резистентность грамотрицательных бактерий, продуцентов карбапенемаз, в Санкт-Петербурге и некоторых других регионах Российской Федерации. Антибиотики и Химиотерапия. 2016;61(11-12):28-38.
For citation:
Lazareva I.V., Ageevets V.A., Ershova T.A., Zueva L.P., Goncharov A.E., Darina M.G., Svetlichnaya Yu.S., Uskov A.N., Sidorenko S.V. Prevalence and Antibiotic Resistance of Carbapenemase-Producing Gram-Negative Bacteria in Saint Petersburg and Some Other Regions of the Russian Federation. Antibiot Khimioter = Antibiotics and Chemotherapy. 2016;61(11-12):28-38. (In Russ.)